Kazakhstan Aims to Reduce Medicine Imports with New Pharmaceutical Plants

Kazakhstan plans to produce nearly 500 types of medicine domestically by 2034 through eight investment projects totaling $862 million. The initiative aims to create over 1,200 jobs and decrease reliance on imported pharmaceuticals, covering treatments for various diseases. The Ministry of Health reported that domestic production currently accounts for 15% of the market value.

Read the full article at Times of Central Asia →

Headline and summary written by daryo. The full report belongs to Times of Central Asia.